Charles River Laboratories (CRL) Tops Q3 EPS by 8c; Narrows Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 326.29 -25.58 (7.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $351.87 | 52 Week High | $89.18 | |||
| Open | $349.90 | 52 Week Low | $65.70 | |||
| Day High | $354.99 | P/E | 151.76 | |||
| Day Low | $325.35 | EPS | $2.15 | |||
| Volume | 1,729,159 | |||||
